Responses
Other responses
Jump to comment:
- Published on: 20 October 2021
- Published on: 20 October 2021A reply to: “Parenteral nutrition for preterm infants: Correcting for arachidonic and docosahexaenoic acid may not suffice” by Bernard et al.
A reply to:
“Parenteral nutrition for preterm infants: Correcting for arachidonic and
docosahexaenoic acid may not suffice” by Bernard et al. regarding the publication:
Frazer LC, Martin CR. Parenteral lipid emulsions in the preterm infant: current issues
and controversies. Arch Dis Child Fetal Neonatal Ed. 2021 Jan 29: fetalneonatal-
2020-319108. doi: 10.1136/archdischild-2020-319108. Epub ahead of print. PMID:
33514630.Lauren C. Frazer1,2, Camilia R. Martin2,3,4
1Division of Newborn Medicine, Boston Children’s Hospital, Boston, MA, USA
2Department of Pediatrics, Harvard Medical School, Boston, MA, USA
3Division of Translational Research, Beth Israel Deaconess Medical Center, Boston, MA, USA 4Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, MA, USA
Correspondence: cmartin1@bidmc.harvard.eduWord Count: 216
Keywords: arachidonic acid, docosahexaenoic acid, lipid emulsions, preterm infant
Dear Editor,
We would like to thank Bernhard and colleagues for their thoughtful letter “Parenteral nutrition for preterm infants: Correcting for arachidonic and docosahexaenoic acid may not suffice” written in response to our review. The authors of the letter raised important issues regarding the lack of data surrounding the optimal balance of arachidonic (ARA) and docosahexaenoic acid (DHA) that should be administered...
Show MoreConflict of Interest:
None declared.